|
Indian Pediatr 2019;56: 508 |
|
Commercializing Donor Human Milk – Nip it in the Bud
|
B Adhisivam* and S Thanigainathan
Department of Neonatology, JIPMER, Puducherry, India.
Email:
[email protected]
|
According to World Health Organization, if mother’s own milk is
unavailable or insufficient, the next best option is to use pasteurized
donor human milk (DHM) [1]. Given the high rate of preterm births in the
country and level of malnutrition that ensues in the postnatal growth of
preterm infants, there is an urgent need to establish Human milk banks
(HMBs) across the country, especially in large neonatal units. Though
the first HMB of India was started in 1989 at Mumbai, the growth of HMBs
has been at a much slower rate than the demand. Nevertheless, there has
been renewed interest in this area over the past few years, and now more
than 50 HMBs are operational in the country [2,3], and a majority of
them are in the public sector. As per National Guidelines on Lactation
Management Centers in Public Health Facilities, donation should be done
freely and voluntarily without any monetary benefits to the donor and
with an understanding that the donated milk may be used to feed the baby
of another mother admitted in the hospital free of any cost [4].
In this context, it is disturbing that there is a
move to commercialize DHM in the country. Certain companies are
clandestinely trying to market DHM as mother’s milk fortifier and also
sell DHM for a price of 300 rupees for 15 ml [5]. The fact is that DHM
is obtained free from mothers, and is pasteurized and marketed with
vested commercial interest. At a phase when lactation management centers
are being streamlined, this commercial perspective is an obstacle that
can derail the progress and functioning of HMBs across the country,
which are solely based on the principle of voluntary human milk
donation. If mothers start selling their milk or companies indirectly do
so, HMBs will run dry and infant formula use will increase. There is
also a risk that DHM may be used for non-scientific indications,
excluding the needy preterm neonates. Stringent laws should be enacted
urgently to stop commercialization of DHM. All stakeholders, including
Ministry of Health and Family Welfare, Government of India, Indian
Academy of Pediatrics, National Neonatology Forum, and Breastfeeding
Promotion Network of India, should step-in and act.
References
1. DeMarchis A, Ballard KI, Mansen KA, Engmann C.
Establishing an integrated human milk banking approach to strengthen
newborn care. J Perinatol. 2017;37:469-4742.
2. Nangia S, Sachdeva RC, Sabharwal V. Human milk
banking: An Indian experience. Neo Reviews. 2018;19;e201.
3. Bhat BV, Adhisivam B. Human milk banking and
challenges in quality control. Indian J Pediatr. 2018;85:255-6.
4. National Guidelines on Lactation Management
Centers in Public Health Facilities. Ministry of Health and Family
Welfare, Government of India. New Delhi, 2017.
5. Proposal to sell mother’s milk sets off alarm
bells. Available from:
https://www.thehindu.com/news/cities/bangalore/Proposal-to-sell-mother%E2%80%99s-milk-sets-off-alarm-bells/article15001608.ece.
Accessed May 10, 2019.
|
|
|
|